Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial
Introduction Patients with a first venous thromboembolism (VTE) are at risk of recurrence. Recurrent VTE (rVTE) can be prevented by extended anticoagulant therapy, but this comes at the cost of an increased risk of bleeding. It is still uncertain whether patients with an intermediate recurrence risk...
Similar Items
-
The Box—eHealth in the Outpatient Clinic Follow-up of Patients With Acute Myocardial Infarction: Cost-Utility Analysis
by: Roderick Willem Treskes, et al.
Published: (2022-04-01) -
The implementation of value-based healthcare: a scoping review
by: Dorine J. van Staalduinen, et al.
Published: (2022-03-01) -
Economic Evaluation of Different Screening Strategies for Severe Combined Immunodeficiency Based on Real-Life Data
by: M. Elske van den Akker-van Marle, et al.
Published: (2021-09-01) -
Correction: Preventive child health care at elementary school age: The costs of routine assessments with a triage approach.
by: Janine Bezem, et al.
Published: (2017-01-01) -
The Methodological Quality and Challenges in Conducting Economic Evaluations of Newborn Screening: A Scoping Review
by: Pasquale Cacciatore, et al.
Published: (2020-11-01)